title: Long-term treatment of metastatic colorectal cancer with panitumumab.
abstract: Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. More than 30% patients present with metastases at diagnoses and will require systemic chemotherapy. In recent years many anti-EGFR targets have been developed. Among them, panitumumab, a fully human IgG2 monoclonal antibody has shown important benefits in the treatment of this disease.
authors.affiliation: Clinical Oncology, Infanta Sofía Hospital, San Sebastián de los Reyes, Madrid.
authors.forename: Miriam
authors.initials: M
authors.lastname: López-Gómez
authors.forename: María
authors.initials: M
authors.lastname: Merino
authors.forename: Enrique
authors.initials: E
authors.lastname: Casado